In this lecture from This is Why, Dr. Busti will break down pioglitazone and the thiazolidinediones (TZDs) so you can confidently explain the mechanism, clinical use, side effects, and key contraindications for type 2 diabetes (T2DM).

You’ll learn how to:

- TZDs (pioglitazone): where they fit in type 2 diabetes (T2DM) therapy

- Mechanism of action: PPAR-γ agonist → increased insulin sensitivity (muscle/adipose) and improved glucose utilization

- Expected impact on A1C reduction and how long these drugs take to show benefit

- Practical comparisons: pioglitazone vs rosiglitazone

Side effects & safety (high yield)

- Weight gain and edema / fluid retention

- Heart failure risk (when to avoid TZDs)

- Fracture risk with TZDs

Drugs covered for SEO / review

- Pioglitazone (primary focus)

- Thiazolidinediones / TZDs (drug class)

- Rosiglitazone (comparison)

The goal = make medical education easy and clinically relevant.

Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/tzd-thiazolidinediones-pioglitazone-type-2-diabetes-pharmacology-review

Get more with a free membership at https://www.thisiswhy.health/

- Access free downloads from our videos 

- Access deep dive content from Dr. Busti

- Organize content via playlists & collections

- Join live Q&A

- Receive member newsletters

- Coupons & discounts for exam prep resources

If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#pioglitazone #thiazolidinediones #tzd #type2diabetes #busti

Disclaimer:

This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.